Activity value 75china Supplier,Last transaction date:
2026-03-30
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for hebei guolong pharmaceutical c from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 7 transactions, with a transaction quantity of 3225 and a transaction weight of 0.
YearTransactionsQuantityWeight
202552676250
2026732250
Bill of lading data
<
1/15
>
Trade date
2026/03/30
B/L No.
——
Suppliers
hebei guolong pharmaceutical c
Buyers
citi pharma pvt ltd.
POLs
——
PODs
lpaf
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
38079.573629
Hs code
29419090
Product tags
bat,azithromycin dihydrate,ipm,ion,chi,gin,pharmaceutical raw material
Product description
DESCRPTION OF GOODS:……. PHARMACEUTICAL RAW MATERIAL............AZITHROMYCIN DIHYDRATE .......BATCH NO : 251207025, 251207026.......MFG DATE : 02/JAN/2026 & 03/JAN/2026..........EXP DATE : 01/JAN/2029 & 02/JAN/2029........QTY : 1000 KGSNET......ORIGIN & SHIPMENT : CHINA...........ZHEJIANG
Expand
Trade date
2026/03/19
B/L No.
——
Suppliers
hebei guolong pharmaceutical c
Buyers
citi pharma pvt ltd.
POLs
——
PODs
lpaf
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
138471.130216
Hs code
29419090
Product tags
bat,chi,ipm,ion,gin,azithromycin,pharmaceutical raw material
Product description
DESCRPTION OF GOODS:……. PHARMACEUTICAL RAW MATERIAL............AZITHROMYCIN .......BATCH NO : 251207021 251207022 251207023 & 251207024.......MFG DATE : 28/12/2025 31/12/2025 31/12/2025 & 01/01/2026..........EXP DATE : 27/12/2028 30/12/2028 30/12/2028 & 31/12/2028........QTY : 1000 KGS NET......ORIGIN & SHIPMENT : CHINA...........ZHEJIANG
Expand
Trade date
2026/03/10
B/L No.
——
Suppliers
hebei guolong pharmaceutical c
Buyers
shaigan pharmaceutical pvt ltd.
POLs
——
PODs
kapw
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
68933.472968
Hs code
29419090
Product tags
drap,azithromycin dihydrate,ce certificate,atta,cle,pharmaceutical raw material,aran,44e
Product description
AZITHROMYCIN DIHYDRATE USP AS PER IVN / PL
Expand
Trade date
2026/01/08
B/L No.
——
Suppliers
hebei guolong pharmaceutical c
Buyers
novamed phamraceuticals pvt ltd.
POLs
——
PODs
lpaf
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
7357.84
Hs code
29419090
Product tags
bat,expiry date,azithromycin dihydrate,olon,shipment from china,heb,t 50,powder form,drum,pharmaceutical raw material,bran,gh
Product description
PHARMACEUTICAL RAW MATERIAL ( AZITHROMYCIN DIHYDRATE ) IN POWDER FORM ...BATCH NO 250607033...MFG DATE 27-06-2025...EXPIRY DATE 26-06-2028...QUANITY 02 DRUM EACH 25 KGS...TOTAL NET WEIGHT 50 KGS...BRAND HEBEI GUOLONG...I/O AND SHIPMENT FROM CHINA
Expand
Trade date
2025/12/20
B/L No.
——
Suppliers
hebei guolong pharmaceutical c
Buyers
semos pharamaceuticals pvt ltd.
POLs
——
PODs
kapw
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
40948.37
Hs code
29419090
Product tags
azithromycin,bat,pharmaceutical raw material,r pharm
Product description
AZITHROMYCIN USP (Pharmaceutical Raw Material for Pharmaceutical Industry),, Batch # 250907019 Mfg dt 04-10-2025 Exp dt 09-10-2028.
Expand
Trade date
2025/12/19
B/L No.
——
Suppliers
hebei guolong pharmaceutical c
Buyers
citi pharma pvt ltd.
POLs
——
PODs
kapw
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
136150.18
Hs code
29419090
Product tags
azithromycin dihydrate,bat,pharmaceutical raw material,r pharm
Product description
PHARMACEUTICAL RAW MATERIAL FOR PHARMA INDUSTRY AZITHROMYCIN DIHYDRATE BATCH NO: 250707023 MFG DATE 07-09-2025 EXP DATE: 06-09-2028
Expand
Trade date
2025/12/09
B/L No.
8554686
Suppliers
hebei guolong pharmaceutical c
Buyers
theon pharmaceuticals ltd.
hebei guolong pharmaceutical c is china Supplier,
and primarily engages in the import and export business of products such as azithromycin,azithromycin dihydrate,ep a.
According to the 52wmb.com global trade database, as of 2026-03-30, the company has completed 457 international trades,
with its main trading regions covering pakistan,india,uzbekistan etc.
The core products include HS29419090,HS29415000,HS2941500009 etc,
often transported via shanghai,port tianjin, port xingang etc,
and its main trading partners are gorang international,theon pharmaceuticals ltd.,anuh pharma ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on hebei guolong pharmaceutical c is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.